+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Continuous Glucose Monitoring Systems Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • PDF Icon

    Report

  • 146 Pages
  • October 2023
  • Region: Global
  • OG Analysis
  • ID: 5147516
UP TO OFF until Dec 31st 2024
The study predicts the short term and long term trends that can shape up the future of the Continuous Glucose Monitoring Systems market including the COVID-19 pandemic implications for Continuous Glucose Monitoring Systems industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Continuous Glucose Monitoring Systems market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Continuous Glucose Monitoring Systems Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Continuous Glucose Monitoring Systems market forecast and Continuous Glucose Monitoring Systems market growth is outlook through 2030.

The report reflects on predictions with 2022 as the base year and 2023-2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Continuous Glucose Monitoring Systems market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Continuous Glucose Monitoring Systems industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Continuous Glucose Monitoring Systems market share in developed countries.

Scope of the research

Continuous Glucose Monitoring Systems Market is analyzed and forecast over the outlook period from 2023 to 2030 By Product including

  • Transmitters and Receivers
  • Sensors
  • Insulin Pumps

Continuous Glucose Monitoring Systems Market is analyzed and forecast over the outlook period from 2023 to 2030 by End User including

  • Hospital
  • Homecare Diagnostics
  • Others
Top Companies Operating in Continuous Glucose Monitoring Systems market include-Abbott Laboratories, Animas Corporation, Baxter International Inc., Dexcom Inc., GlySens Incorporated, Medtronic Inc., Novo Nordisk, Pfizer Inc., 1Roche Diagnostics, 1Ypsomed AG


This product will be delivered within 1-3 business days.

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Continuous Glucose Monitoring Systems Market-Key Findings, 2022
3. Strategic Imperatives on Global Continuous Glucose Monitoring Systems Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends-Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Continuous Glucose Monitoring Systems Companies
4. Continuous Glucose Monitoring Systems Market Value Outlook to 2030, by Product
4.1 Transmitters and Receivers
4.2 Sensors
4.3 Insulin Pumps
5. Continuous Glucose Monitoring Systems Market Value Outlook to 2030, by End-User
5.1 Hospital
5.2 Homecare Diagnostics
5.3 Others
6 Asia Pacific Continuous Glucose Monitoring Systems Market Value Outlook to 2030
6.1 Leading Continuous Glucose Monitoring Systems Types contributing to Asia Pacific market
6.2 Top Applications contributing to Asia Pacific Continuous Glucose Monitoring Systems
6.3 Top countries contributing to Asia Pacific Continuous Glucose Monitoring Systems
7 Europe Continuous Glucose Monitoring Systems Market Value Outlook to 2030
7.1 Leading Continuous Glucose Monitoring Systems Types contributing to Europe market
7.2 Top Applications contributing to Europe Continuous Glucose Monitoring Systems
7.3 Top countries contributing to Europe Continuous Glucose Monitoring Systems
8 North America Continuous Glucose Monitoring Systems Market Value Outlook to 2030
8.1 Leading Continuous Glucose Monitoring Systems Types contributing to North America market
8.2 Top Applications contributing to North America Continuous Glucose Monitoring Systems
8.3 Top countries contributing to North America Continuous Glucose Monitoring Systems
9 South and Central America Continuous Glucose Monitoring Systems Market Value Outlook to 2030
9.1 Leading Continuous Glucose Monitoring Systems Types contributing to South and Central America market
9.2 Top Applications contributing to South and Central America Continuous Glucose Monitoring Systems
9.3 Top countries contributing to South and Central America Continuous Glucose Monitoring Systems
10 Middle East Africa Continuous Glucose Monitoring Systems Market Value Outlook to 2030
10.1 Leading Continuous Glucose Monitoring Systems Types contributing to Middle East Africa market
10.2 Top Applications contributing to Middle East Africa Continuous Glucose Monitoring Systems
10.3 Top countries contributing to Middle East Africa Continuous Glucose Monitoring Systems
11 Business Profiles of Leading Companies
11.1 Business Description, SWOT and Financial Analysis of Companies in Continuous Glucose Monitoring Systems market
11.2 Abbott Laboratories
11.3 Animas Corporation
11.4 Baxter International Inc.
11.5 Dexcom Inc.
11.6 GlySens Incorporated
11.7 Medtronic Inc.
11.8 Novo Nordisk
11.9 Pfizer Inc.
11.10 Roche Diagnostics
11.11 Ypsomed AG
12 Recent Industry Developments
13 Appendix
13.1 Analyst's Expertise
13.2 Sources and Methodology
13.3 Contacts

Companies Mentioned

  • Abbott Laboratories
  • Animas Corporation
  • Baxter International Inc.
  • Dexcom Inc.
  • Glysens Incorporated
  • Medtronic Inc.
  • Novo Nordisk
  • Pfizer Inc.
  • Roche Diagnostics
  • Ypsomed Ag

Methodology

Loading
LOADING...